Ubs Asset Management Americas Inc Johnson & Johnson Transaction History

Ubs Asset Management Americas Inc

$345 Billion
Q2 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 18,012,348 shares of JNJ stock, worth $2.88 Billion. This represents 0.76% of its overall portfolio holdings.

Number of Shares

18,012,348

Previous 13,228,564 36.16%

Holding current value

$2.88 Billion

Previous $2.09 Billion 25.81%

% of portfolio

0.76%

Previous 0.76%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $691 Million - $755 Million	4,783,784 Added 36.16%	18,012,348 $2.63 Billion
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $142 Million - $148 Million	-912,112 Reduced 6.45%	13,228,564 $2.09 Billion
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $442 Million - $483 Million	3,037,885 Added 27.36%	14,140,676 $2.22 Billion
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $16.6 Million - $18.6 Million	-106,577 Reduced 0.95%	11,102,791 $1.73 Billion
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $24.9 Million - $29.8 Million	165,097 Added 1.49%	11,209,368 $1.74 Billion
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $95.9 Million - $108 Million	598,643 Added 5.73%	11,044,271 $1.95 Billion
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $4.79 Million - $5.33 Million	-29,708 Reduced 0.28%	10,445,628 $1.71 Billion
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $21.5 Million - $23.8 Million	-128,050 Reduced 1.21%	10,475,336 $1.86 Billion
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $57.2 Million - $65 Million	-362,015 Reduced 3.3%	10,603,386 $1.88 Billion
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $48.8 Million - $54.2 Million	-313,188 Reduced 2.78%	10,965,401 $1.88 Billion
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $97.3 Million - $108 Million	602,259 Added 5.64%	11,278,589 $1.82 Billion
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $37.5 Million - $40.2 Million	235,054 Added 2.25%	10,676,330 $1.76 Billion
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $13.7 Million - $15.2 Million	-89,205 Reduced 0.85%	10,441,276 $1.72 Billion
Q4 2020 Mar 01, 2021	BUY	$137.11 - $157.38 $68.5 Million - $78.6 Million	499,411 Added 4.98%	10,530,481 $1.66 Billion
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $94.8 Million - $104 Million	-675,302 Reduced 6.31%	10,031,070 $1.49 Billion
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $97.4 Million - $118 Million	-756,161 Reduced 6.6%	10,706,372 $1.51 Billion
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $95.6 Million - $132 Million	859,767 Added 8.11%	11,462,533 $1.5 Billion
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $56.5 Million - $64.9 Million	-443,499 Reduced 4.01%	10,602,766 $1.55 Billion
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $81.5 Million - $91.3 Million	-642,264 Reduced 5.49%	11,046,265 $1.43 Billion
Q2 2019 Aug 15, 2019	SELL	$131.15 - $144.24 $180 Million - $198 Million	-1,369,706 Reduced 10.49%	11,688,529 $0
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $62.7 Million - $69.7 Million	498,553 Added 3.97%	13,058,235 $0
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $135 Million - $163 Million	1,100,018 Added 9.6%	12,559,682 $1.62 Billion
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $2.6 Million - $3.06 Million	21,385 Added 0.19%	11,459,664 $0
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $36.5 Million - $40.3 Million	-305,795 Reduced 2.6%	11,438,279 $0
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $156 Million - $185 Million	1,247,631 Added 11.89%	11,744,074 $0
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $174 Million - $190 Million	1,324,868 Added 14.45%	10,496,443 $0
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $1.19 Billion - $1.24 Billion	9,171,575	9,171,575 $0

Others Institutions Holding JNJ

# of Institutions

4,219

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Johnson & Johnson Transaction History